Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

58.88
Delayed Data
As of 3:59pm ET
 +0.20 / +0.34%
Today’s Change
30.00
Today|||52-Week Range
62.50
+5.94%
Year-to-Date

Today’s Trading

Previous close58.68
Today’s open58.89
Day’s range58.13 - 59.80
Volume780,666
Average volume (3 months)852,146
Market cap$9.0B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+191.99%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book7.40

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc+0.47+0.74%
JAZZJazz Pharmaceuticals...+0.64+0.45%
TSROTESARO Inc+6.38+4.15%
PRGOPerrigo Company PLC-0.20-0.29%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs